Analyst consensus rating
Obsidian Therapeutics Analyst Rating: Strong Buy
Direct answer
Obsidian Therapeutics's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $39.00.
Forecast evidence checked November 13, 2026.
Get free Obsidian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.48
- Average price target
- $39.00
- High price target
- $43.00
- Low price target
- $32.00
- Low target gap
- +156.4%
- Target upside
- +212.5%
- High target gap
- +244.6%
- Target range width
- 88.1%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Obsidian Therapeutics?
Obsidian Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $39.00.
How far are Obsidian Therapeutics's low and high targets from the recorded price?
The low target implies +156.4%, while the high target implies +244.6%.
How many analysts are included in Obsidian Therapeutics's consensus?
The verified consensus includes 3 analysts.
How is Obsidian Therapeutics's target upside or downside calculated?
The average target of $39.00 is divided by the recorded price of $12.48, then one is subtracted to produce +212.5%. This does not guarantee a future return.
When was Obsidian Therapeutics's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.